News
![AstraZeneca (AZ)](https://pharmaphorum.com/wp-content/uploads/2012/08/Astrazeneca.jpg)
AZ’s Tagrisso wins new NSCLC first-line approval in Europe
AstraZeneca has widened the licence for its cancer drug Tagrisso (osimertinib) in Europe after regulators gave it the green-light for first-line use against additional types of non-small ce